Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Maury Raycroft Initiated (TPST) at Strong Buy and Held Target at $15 on, Feb 8th, 2024
Maury Raycroft of Jefferies, Initiated "Tempest Therapeutics, Inc." (TPST) at Strong Buy and Held Target at $15 on, Feb 8th, 2024.
Maury has made no other calls on TPST in the last 4 months.
There is 1 other peer that has a rating on TPST. Out of the 1 peers that are also analyzing TPST, 0 agree with Maury's Rating of Hold.
This is the rating of the analyst that currently disagrees with Maury
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $47 on, Wednesday, October 11th, 2023
